Anzeige
Mehr »
Donnerstag, 14.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
435 Leser
Artikel bewerten:
(1)

Inspirata, Inc.: Inspirata Europe Achieves ISO 9001 Certification and the Inclusion of its Cancer AI on NHS Supply Chain Frameworks

London, United Kingdom, July 07, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that its UK subsidiary, Inspirata Europe, has achieved certification to ISO 9001 Quality Management System, and UK government-backed cybersecurity accreditation, Cyber Essentials and Cyber Essential Plus. Achieving ISO 9001 also sees Inspirata's pathology and oncology AI solutions approved for full inclusion on the Medical IT Departmental Software and Hardware Solutions framework operated by NHS Supply Chain.

"Securing these various external certifications is a testament to the high levels of regulatory and quality governance we practise as a company, the hard work and fabulous talent of our European team and our commitment to making it as easy as possible for the NHS to work with Inspirata," says Satish Sanan, CEO, Inspirata. "We look forward to supporting the NHS and its incredible staff make every moment matter in the global fight against cancer."

Inspirata offers intelligent automation solutions which utilise oncology- and pathology-specific natural language processing (NLP) and AI to interrogate and make immediate sense of the thousands of complex and frequently unstructured medical reports and documentation a hospital produces each day. Cancer centres around the globe draw on this automation technology to improve the timeliness, accuracy and completeness of their cancer reporting, accelerate the identification of eligible cancer patients for clinical trials, and to expedite the return of clinical insights. All Inspirata cancer informatics offerings will now be available for purchase by the NHS.

"It is imperative that all vendors looking to work with the NHS Supply Chain are evaluated to the very highest standards prior to inclusion in our frameworks," says John Lambert, Medical IT Buyer at NHS Supply Chain. "Independent accreditation of Inspirata's quality management processes represented the final step in achieving our full approval and we now welcome being able to admit its various cancer informatics AI software onto our medical IT framework."

The process of obtaining ISO 9001 certification started in late 2020 and involved back-to-back Stage One and Stage Two audits by BSI, in the spring of this year. External counsel for both ISO 9001 and Cyber Essentials accreditation was provided by Information Assurance for Small and Medium Enterprises Consortium (IASME) organisation Hytec Information Security.

"Inspirata Europe has successfully demonstrated a quality management system for the provision of pre-sales and project management for healthcare-related AI software applications which meets the requirements of ISO 9001. I would like to congratulate them on this achievement which allows organisations to continually improve and satisfy customers," says Matt Mato, Client Manager, BSI.

"Inspirata's success across multiple different awards is a reflection of the organisation's relentless focus on ensuring its solutions, systems and processes are always architected to the very highest standards," says Jonathan Barr, Client Manager at Hytec Information Security Ltd. "Inspirata represent model clients and Hytec is proud of its role in helping the UK team achieve relevant data security and quality management accreditation consistent with offering their software services here in the United Kingdom."

Inspirata Europe already possess local customers for digital pathology and are close to a number of new customers announcements with its cancer informatics toolsets.

"Inspirata offer all the agility and creativity you commonly expect from a fast-growing technology start-up but are able to combine it with the quality safeguards and guarantees typically only seen with more established companies," says Oenone Duroe, General Manager, Inspirata Europe. "This is already proving to be an extremely attractive proposition with local audiences wishing to deploy our intelligent automation solutions."

About Inspirata Europe Ltd.

Inspirata Europe helps patients fighting cancer-and the clinicians they trust-to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.

Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated cancer registry solutions, comprehensive cancer informatics and advanced patient engagement tools to bring users the broadest oncology informatics platform available globally. For more information, please visit www.inspirata.comor contact info@inspirata.com.

For further information about Inspirata, please contact:

Graeme Collins
Inspirata Europe, Ltd.
Tel: +44 (0)330 330 9038
E-mail: gcollins@inspirata.com


© 2021 GlobeNewswire (Europe)
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.